PFAS cosmetics ban

Summary#

This bill would add a new ban on intentionally added perfluoroalkyl or polyfluoroalkyl substances (PFAS) in cosmetics by changing the Federal Food, Drug, and Cosmetic Act. The ban would treat cosmetics that contain intentionally added PFAS as "adulterated" (illegal to sell). The new rule would start on January 1, 2027. The bill also repeals a specific provision from the 2022 Modernization of Cosmetics Regulation Act.

  • Main change: any cosmetic that contains an intentionally added PFAS would be considered adulterated and therefore not lawful under the Federal Food, Drug, and Cosmetic Act.
  • Definition: PFAS are defined broadly as fluorinated organic chemicals that include at least one fully fluorinated methyl or methylene carbon atom.
  • "Intentionally added": covers PFAS deliberately added for a technical or functional purpose, and PFAS that are intentional breakdown products of an added chemical.
  • Effective date: the ban applies beginning January 1, 2027.
  • Repeal: the bill repeals section 3506 of the Modernization of Cosmetics Regulation Act of 2022; the bill text does not explain the practical effect of that repeal.

What it means for you#

  • Cosmetic manufacturers and ingredient suppliers
    • Must not put PFAS into cosmetics sold in the U.S. after Jan 1, 2027.
    • May need to reformulate products, change ingredient sourcing, and test ingredients and finished products to show PFAS were not intentionally added.
  • Importers and retailers
    • Could face enforcement actions if they sell cosmetics that contain intentionally added PFAS.
    • May need to check supplier documentation and test products to avoid carrying banned items.
  • Consumers
    • Products on store shelves and online that have PFAS intentionally added would be banned starting Jan 1, 2027.
    • The bill does not require new labeling rules or consumer notices in the text.
  • Government agencies
    • The change makes cosmetics with intentionally added PFAS unlawful under the FD&C Act, which is enforced under existing food and drug laws. The bill does not describe new enforcement procedures or funding.
  • What is unclear:
    • The bill does not set a numerical limit or threshold for PFAS traces (for example, whether tiny contaminants are allowed).
    • The bill does not explain how regulators should test for or prove that PFAS were "intentionally added."
    • The practical effect of repealing section 3506 of the 2022 law is not explained in the bill text.

Expenses#

No publicly available information.

  • The bill text and supplied materials do not include a fiscal note or cost estimate.
  • This would likely increase compliance costs for manufacturers and importers (testing, reformulation, supply-chain checks). These are likely private costs; the bill does not provide numbers.
  • Enforcement could require additional FDA resources, testing, or inspections; the bill does not specify funding or staffing changes.
  • The repeal of the 2022 statutory provision could change administrative costs or processes, but the bill does not explain the financial effect.

Proponents' View#

  • The bill appears intended to prevent the intentional use of PFAS in cosmetics.
  • A possible argument for the bill is that banning intentional addition could reduce consumer exposure to PFAS from personal-care products.
  • A class-based definition (covering chemicals that share a structural feature) may be intended to stop manufacturers from switching to chemically similar PFAS to evade a narrower ban.
  • Making cosmetics with intentionally added PFAS "adulterated" uses existing drug and food law tools to remove products from the market.

Opponents' View#

  • One concern is that the bill does not explain how regulators will prove a PFAS was "intentionally added" versus present as an impurity or contamination.
  • The bill sets no numeric testing limits or detection thresholds. This raises questions about trace amounts and enforcement fairness.
  • The broad chemical definition could cover many substances; this may make compliance and testing more complicated and costly for manufacturers.
  • Repealing a section of the 2022 cosmetics law may change regulatory processes, but the bill does not say how or why, leaving uncertainty about administrative effects.
  • Enforcement may require more FDA testing and oversight, but the bill does not include funding or detailed enforcement steps.